US Stock MarketDetailed Quotes

SGMO Sangamo Therapeutics

Watchlist
  • 0.871
  • +0.166+23.61%
Close Aug 2 16:00 ET
  • 0.860
  • -0.011-1.30%
Post 19:59 ET
180.78MMarket Cap-465P/E (TTM)

Sangamo Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Sangamo Therapeutics Earnings Date

Currency: USD

Period

Q2 FY2024 Estimates

Aug 6, 2024

Revenue(YoY)

8.26M

+20.85%
EPS(YoY)

-0.15

+77.85%
Analyst Rating

Strong Buy

Jul 31, 2024

Sangamo Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 8.720M--
Aug 6, 20242024/Q2-- / 8.260M--
May 9, 20242024/Q1481.000K / 6.361M--
--2023/Q42.042M / 8.105M--
Nov 1, 20232023/Q39.398M / 10.404M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 8.720M--
Aug 6, 20242024/Q2-- / 8.260M--
May 9, 20242024/Q1481.000K / 6.361M--
--2023/Q42.042M / 8.105M--
Nov 1, 20232023/Q39.398M / 10.404M--

Unlock Free Earnings Estimates

Sangamo Therapeutics Earnings Reports

  • Sangamo Therapeutics | 10-Q: Quarterly report

    May 9 16:10 ET

  • Sangamo Therapeutics | 10-K: Annual report

    Mar 13 07:53 ET

  • Sangamo Therapeutics | 10-Q: Q3 2023 Earnings Report

    Nov 1, 2023 16:17 ET

  • Sangamo Therapeutics | 10-Q: Q2 2023 Earnings Report

    Aug 8, 2023 16:15 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 31, 2024

    Strong Buy

    • Buy

      75.00%

    • Hold

      25.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg
    Concept Gene Editing
    Gene Editing
    Intraday-2.47%
    Top Gainers Yesterday
    Top Gainers Yesterday
    Intraday-3.72%